EH
NVO

Equitable Holdings’s Novo Nordisk NVO Stock Holding History

Equitable Holdings’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.8M Buy
58,349
+15,177
+35% +$652K 0.02% 629
2026
Q1 		$2.11M Sell
43,172
-1,117
-3% -$52.9K 0.01% 700
2025
Q4 		$2.25M Sell
44,289
-4,649
-9% -$238K 0.02% 598
2025
Q3 		$2.72M Sell
48,938
-792
-2% -$46.4K 0.02% 512
2025
Q2 		$3.43M Sell
49,730
-1,687
-3% -$115K 0.03% 421
2025
Q1 		$3.57M Buy
51,417
+141
+0.3% +$11.6K 0.03% 369
2024
Q4 		$4.41M Sell
51,276
-24,843
-33% -$2.69M 0.04% 309
2024
Q3 		$9.06M Buy
76,119
+13,117
+21% +$1.75M 0.09% 188
2024
Q2 		$8.99M Buy
63,002
+7,973
+14% +$1.06M 0.09% 173
2024
Q1 		$7.07M Buy
55,029
+25,057
+84% +$2.98M 0.08% 187
2023
Q4 		$3.1M Buy
29,972
+17,681
+144% +$1.75M 0.04% 304
2023
Q3 		$1.12M Buy
12,291
+2,271
+23% +$200K 0.02% 515
2023
Q2 		$811K Buy
10,020
+6,326
+171% +$517K 0.01% 576
2023
Q1 		$294K Buy
+3,694
New +$262K ﹤0.01% 804

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Equitable Holdings's NVO Position: Q2 2026 in Review

Equitable Holdings increased its Novo Nordisk (NVO) stake by 35% in Q2 2026, buying an estimated $652K and bringing the position to 58,349 shares worth $2.8M. The position accounts for 0.02% of the portfolio, ranked #629.

Equitable Holdings first reported a position in NVO in Q1 2023 and has held it in 14 quarters since. The position peaked at $9.06M in Q3 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Equitable Holdings held 58,349 shares of Novo Nordisk worth $2.8M as of Q2 2026.
  • Equitable Holdings bought 15,177 Novo Nordisk shares in Q2 2026, an estimated $652K.
  • Novo Nordisk made up 0.02% of Equitable Holdings's portfolio in Q2 2026, its #629 holding.
  • Equitable Holdings first reported a position in Novo Nordisk in Q1 2023 and has held it in 14 quarters since.
  • Equitable Holdings's Novo Nordisk position peaked at $9.06M in Q3 2024.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.